Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

Triple Negative Breast Cancers (TNBC) subtype is an aggressive disease with poor clinical outcome. The only treatment available is surgery followed by chemotherapy or radiotherapy. Programmed death-ligand 1 (PD-L1) is a trans-membrane protein expressed on a wide variety of cells including immune cel...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Mol Sci
Autori principali: Botti, Gerardo, Collina, Francesca, Scognamiglio, Giosuè, Rao, Federica, Peluso, Valentina, De Cecio, Rossella, Piezzo, Michela, Landi, Gabriella, De Laurentiis, Michelino, Cantile, Monica, Di Bonito, Maurizio
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2017
Soggetti:
Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5343992/
https://ncbi.nlm.nih.gov/pubmed/28230773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18020459
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi